Pharmacol Res News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmacol res. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmacol Res Today - Breaking & Trending Today

Have Children Truly Ever Been 'Therapeutic Orphans?'

Imposing the FDA on-label/off-label framework on administratively defined "children" resulted in a regulatory demand for pediatric studies that had no basis in clinical medicine, with the exception of the small group of preterm newborns. ....

United States , Basel Stadt , United Kingdom , City Of , Gianvincenzo Zuccotti , Massimo Molteni , Harry Shirkey , Earlb Ettienne , J Clin Pharmacolog , J Clin Pharmacol , Klaus Rose , Emilio Clementi , Japanese Society For Pediatric Clinical Pharmacology , College Of Pharmacy , European Parliament , European Society For Developmental , Unlicensed Use On Health Care Laws , Mathis Ll Eds Pediatric Drug Development , Network Historical , European Medicines Agency , Us Department Of Health , Drug Law Institute , Human Services , European Society For Perinatal , Revolution In Pediatric Drug Development , Ethics International ,

SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk

With increasing use of sodium glucose cotransporter 2 (SGLT2) inhibitors, investigators are taking a closer look at potential adverse events. ....

United States , South Korea , Brian Chiang , Mitsuboshi Satoru , Bonggi Kim , Jan Menne , Korean National Health Insurance Service , Flinders Medical Centre , International Journal Of Cardiology , Pharmacology Research Perspectives , Hannover Medical School In , Korea Institute Of Drug Safety , Harvard Medical School , Hannover Medical School , American Journal , Kidney Disease , Elisabetta Patorno , Event Reporting System , Kaetsu Hospital , Medical Data Vision , Korea Institute , Drug Safety , Risk Management , Pharmacology Research , International Journal , Pharmacol Res ,

SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk

With increasing use of sodium glucose cotransporter 2 (SGLT2) inhibitors, investigators are taking a closer look at potential adverse events. ....

United States , South Korea , Brian Chiang , Mitsuboshi Satoru , Bonggi Kim , Jan Menne , Korean National Health Insurance Service , Flinders Medical Centre , International Journal Of Cardiology , Pharmacology Research Perspectives , Hannover Medical School In , Korea Institute Of Drug Safety , Harvard Medical School , Hannover Medical School , American Journal , Kidney Disease , Elisabetta Patorno , Event Reporting System , Kaetsu Hospital , Medical Data Vision , Korea Institute , Drug Safety , Risk Management , Pharmacology Research , International Journal , Pharmacol Res ,